Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells

被引:146
|
作者
Lim, S. Y. [1 ]
Yuzhalin, A. E. [1 ]
Gordon-Weeks, A. N. [1 ]
Muschel, R. J. [1 ]
机构
[1] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England
关键词
CALCIUM-BINDING PROTEINS; MYELOID CELLS; MATRIX METALLOPROTEINASES; OXIDATIVE MODIFICATIONS; ROLES; METASTASIS; DIFFERENTIATION; INFLAMMATION; RECRUITMENT; PROGRESSION;
D O I
10.1038/onc.2016.107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloid cells promote the development of distant metastases, but little is known about the molecular mechanisms underlying this process. Here we have begun to uncover the effects of myeloid cells on cancer cells in a mouse model of liver metastasis. Monocytes/macrophages, but not granulocytes, isolated from experimental liver metastases stimulated migration and invasion of MC38 colon and Lewis lung carcinoma cells. In response to conditioned media from tumor-infiltrating monocytes/macrophages, cancer cells upregulated S100a8 and S100a9 messenger RNA expression through an extracellular signal-related kinase-dependent mechanism. Suppression of S100A8 and S100A9 in cancer cells using short hairpin RNA significantly diminished migration and invasion in culture. Downregulation of S100A8 and S100A9 had no effect on subcutaneous tumor growth. However, colony size was greatly reduced in liver metastases with decreased invasion into adjacent tissue. In tissue culture and in the liver colonies derived from cancer cells with knockdown of S100A8 and S100A9, MMP2 and MMP9 expression was decreased, consistent with the reduction in migration and invasion. Our findings demonstrate that monocytes/macrophages in the metastatic liver microenvironment induce S100A8 and S100A9 in cancer cells, and that these proteins are essential for tumor cell migration and invasion. S100A8 and S100A9, however, are not responsible for stimulation of proliferation. This study implicates S100A8 and S100A9 as important mediators of tumor cell aggressiveness, and highlights the therapeutic potential of S100A8 and S100A9 for interference of metastasis.
引用
收藏
页码:5735 / 5745
页数:11
相关论文
共 50 条
  • [1] Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells
    S Y Lim
    A E Yuzhalin
    A N Gordon-Weeks
    R J Muschel
    Oncogene, 2016, 35 : 5735 - 5745
  • [2] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [3] The role of the S100A8/S100A9 in gastric tumor progression
    Fang, Shuangshuang
    Du, Sijing
    Luo, Xiaoying
    Qing, Xiangli
    Wang, Lin
    Ban, Yanran
    Song, Gengqing
    Yang, Yang
    Wei, Wei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] S100A8 and S100A9 in inflammation and cancer
    Gebhardt, Christoffer
    Nemeth, Julia
    Angel, Peter
    Hess, Jochen
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1622 - 1631
  • [5] The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma:: The S100A9 and S100A8 positive cells underlie and invade tumor mass
    Stulík, J
    Österreicher, J
    Koupilová, K
    Knízek, J
    Macela, A
    Bures, J
    Jandík, P
    Langr, F
    Dedic, K
    Jungblut, PR
    ELECTROPHORESIS, 1999, 20 (4-5) : 1047 - 1054
  • [6] S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells
    Lee, Ji-Sook
    Lee, Na Rae
    Kashif, Ayesha
    Yang, Seung-Ju
    Nam, A. Reum
    Song, Ik-Chan
    Gong, Soo-Jung
    Hong, Min Hwa
    Kim, Geunyeong
    Seok, Pu Reum
    Lee, Myung-Shin
    Sung, Kee-Hyung
    Kim, In Sik
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [7] S100A8 and S100A9 positive cells in colorectal carcinoma
    Bassorgun, C. I.
    Ozluk, A.
    Erin, N.
    Uzun, O. C.
    Elpek, G. O.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 209 - 209
  • [8] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651
  • [9] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
  • [10] S100A8 and S100A9 in inflammatory diseases
    Roth, J
    Goebeler, M
    Sorg, C
    LANCET, 2001, 357 (9261): : 1041 - 1041